Galecto Inc (GLTO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: GLTO Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-07	2025-01-03	S Sale	Firmani Lori Interim CFO Officer	261 -36.0% 5.63 USD 1,469	261 -36.0%	5.63	USD 1,469
2025-01-07	2025-01-03	S Sale	Schambye Hans T. Chief Executive Officer Executive Director	1,341 -28.3% 5.60 USD 7,510	1,341 -28.3%	5.60	USD 7,510
2025-01-07	2025-01-03	S Sale	Winslow Garrett General Counsel Officer	471 -31.8% 5.60 USD 2,638	471 -31.8%	5.60	USD 2,638
2023-08-17	2023-08-15	S Sale	ORBIMED ADVISORS LLC Large shareholder	535,534 -26.2% 0.75 USD 401,651	535,534 -26.2%	0.75	USD 401,651
2023-08-17	2023-08-15	S Sale	ORBIMED ADVISORS LLC Large shareholder	248,819 -28.3% 0.75 USD 186,614	248,819 -28.3%	0.75	USD 186,614
2023-08-17	2023-08-15	S Sale	ORBIMED ADVISORS LLC Large shareholder	38,327 -28.3% 0.75 USD 28,745	38,327 -28.3%	0.75	USD 28,745
2023-08-02	2023-07-31	S Sale	ORBIMED ADVISORS LLC Large shareholder	153,078 -6.8% 3.00 USD 459,234	153,078 -6.8%	3.00	USD 459,234
2023-08-02	2023-07-31	S Sale	ORBIMED ADVISORS LLC Large shareholder	29,700 -3.3% 3.00 USD 89,100	29,700 -3.3%	3.00	USD 89,100
2023-08-02	2023-07-31	S Sale	ORBIMED ADVISORS LLC Large shareholder	26,622 -16.4% 3.00 USD 79,866	26,622 -16.4%	3.00	USD 79,866
2023-07-27	2023-07-25	S Sale	ORBIMED ADVISORS LLC Large shareholder	26,700 -1.2% 2.92 USD 77,964	26,700 -1.2%	2.92	USD 77,964
2023-07-27	2023-07-25	S Sale	ORBIMED ADVISORS LLC Large shareholder	4,700 -0.5% 2.92 USD 13,724	4,700 -0.5%	2.92	USD 13,724
2023-07-27	2023-07-25	S Sale	ORBIMED ADVISORS LLC Large shareholder	7,800 -4.6% 2.92 USD 22,776	7,800 -4.6%	2.92	USD 22,776
2023-07-17	2023-07-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	132,100 -5.5% 2.40 USD 317,040	132,100 -5.5%	2.40	USD 317,040
2023-07-17	2023-07-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	52,800 -5.5% 2.40 USD 126,720	52,800 -5.5%	2.40	USD 126,720
2023-07-17	2023-07-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	9,800 -5.5% 2.40 USD 23,520	9,800 -5.5%	2.40	USD 23,520
2023-04-17	2023-04-17	S Sale	ORBIMED ADVISORS LLC Large shareholder	8,878 -0.4% 1.97 USD 17,490	8,878 -0.4%	1.97	USD 17,490
2023-04-17	2023-04-17	S Sale	ORBIMED ADVISORS LLC Large shareholder	3,551 -0.4% 1.97 USD 6,995	3,551 -0.4%	1.97	USD 6,995
2023-04-17	2023-04-17	S Sale	ORBIMED ADVISORS LLC Large shareholder	660 -0.4% 1.97 USD 1,300	660 -0.4%	1.97	USD 1,300
2023-04-17	2023-04-14	S Sale	ORBIMED ADVISORS LLC Large shareholder	28,110 -1.1% 1.86 USD 52,285	28,110 -1.1%	1.86	USD 52,285
2023-04-17	2023-04-14	S Sale	ORBIMED ADVISORS LLC Large shareholder	11,245 -1.1% 1.86 USD 20,916	11,245 -1.1%	1.86	USD 20,916
2023-04-17	2023-04-14	S Sale	ORBIMED ADVISORS LLC Large shareholder	2,091 -1.1% 1.86 USD 3,889	2,091 -1.1%	1.86	USD 3,889
2023-04-17	2023-04-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	9,459 -0.4% 1.82 USD 17,215	9,459 -0.4%	1.82	USD 17,215
2023-04-17	2023-04-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	3,784 -0.4% 1.82 USD 6,887	3,784 -0.4%	1.82	USD 6,887
2023-04-17	2023-04-13	S Sale	ORBIMED ADVISORS LLC Large shareholder	703 -0.4% 1.82 USD 1,279	703 -0.4%	1.82	USD 1,279
2023-04-12	2023-04-12	S Sale	ORBIMED ADVISORS LLC Large shareholder	1,603 -0.1% 1.81 USD 2,901	1,603 -0.1%	1.81	USD 2,901
2023-04-12	2023-04-12	S Sale	ORBIMED ADVISORS LLC Large shareholder	641 -0.1% 1.81 USD 1,160	641 -0.1%	1.81	USD 1,160
2023-04-12	2023-04-12	S Sale	ORBIMED ADVISORS LLC Large shareholder	119 -0.1% 1.81 USD 215	119 -0.1%	1.81	USD 215
2023-04-12	2023-04-11	S Sale	ORBIMED ADVISORS LLC Large shareholder	9,459 -0.4% 1.82 USD 17,215	9,459 -0.4%	1.82	USD 17,215
2023-04-12	2023-04-11	S Sale	ORBIMED ADVISORS LLC Large shareholder	3,784 -0.4% 1.82 USD 6,887	3,784 -0.4%	1.82	USD 6,887
2023-04-12	2023-04-11	S Sale	ORBIMED ADVISORS LLC Large shareholder	703 -0.4% 1.82 USD 1,279	703 -0.4%	1.82	USD 1,279
2023-04-12	2023-04-10	S Sale	ORBIMED ADVISORS LLC Large shareholder	34,745 -1.4% 1.79 USD 62,194	34,745 -1.4%	1.79	USD 62,194
2023-04-12	2023-04-10	S Sale	ORBIMED ADVISORS LLC Large shareholder	13,899 -1.4% 1.79 USD 24,879	13,899 -1.4%	1.79	USD 24,879
2023-04-12	2023-04-10	S Sale	ORBIMED ADVISORS LLC Large shareholder	2,584 -1.4% 1.79 USD 4,625	2,584 -1.4%	1.79	USD 4,625
2023-04-07	2023-04-06	S Sale	ORBIMED ADVISORS LLC Large shareholder	6,558 -0.3% 2.00 USD 13,116	6,558 -0.3%	2.00	USD 13,116
2023-04-07	2023-04-06	S Sale	ORBIMED ADVISORS LLC Large shareholder	2,620 -0.3% 2.00 USD 5,240	2,620 -0.3%	2.00	USD 5,240
2023-04-07	2023-04-06	S Sale	ORBIMED ADVISORS LLC Large shareholder	487 -0.3% 2.00 USD 974	487 -0.3%	2.00	USD 974
2023-04-07	2023-04-05	S Sale	ORBIMED ADVISORS LLC Large shareholder	63,058 -2.4% 2.18 USD 137,466	63,058 -2.4%	2.18	USD 137,466
2023-04-07	2023-04-05	S Sale	ORBIMED ADVISORS LLC Large shareholder	25,220 -2.4% 2.18 USD 54,980	25,220 -2.4%	2.18	USD 54,980
2023-04-07	2023-04-05	S Sale	ORBIMED ADVISORS LLC Large shareholder	4,687 -2.4% 2.18 USD 10,218	4,687 -2.4%	2.18	USD 10,218
2022-03-23	2022-03-22	B Purchase	Schambye Hans T. Chief Executive Officer Executive Director	5,000 +10.5% 2.15 USD 10,750	5,000 +10.5%	2.15	USD 10,750
2022-03-23	2022-03-22	B Purchase	Lindmark Bertil Chief Medical Officer Officer	14,604 +730.2% 2.16 USD 31,545	14,604 +730.2%	2.16	USD 31,545
2021-12-06	2021-12-03	B Purchase	Freve Jonathan Chief Financial Officer Officer	4,000 +50.0% 2.49 USD 9,960	4,000 +50.0%	2.49	USD 9,960
2021-12-06	2021-12-03	B Purchase	Winslow Garrett General Counsel Officer	2,000 +100.0% 2.48 USD 4,960	2,000 +100.0%	2.48	USD 4,960
2021-11-10	2021-11-09	B Purchase	Schambye Hans T. Chief Executive Officer Executive Director	4,500 +10.5% 3.50 USD 15,750	4,500 +10.5%	3.50	USD 15,750
2021-11-09	2021-11-08	B Purchase	Freve Jonathan Chief Financial Officer Officer	3,000 +60.0% 3.40 USD 10,200	3,000 +60.0%	3.40	USD 10,200
2021-06-28	2021-06-28	B Purchase	Lindmark Bertil Chief Medical Officer Officer	2,000 +inf% 5.26 USD 10,520	2,000 +inf%	5.26	USD 10,520
2021-06-24	2021-06-24	B Purchase	Schambye Hans T. Chief Executive Officer Executive Director	3,000 +7.5% 5.11 USD 15,330	3,000 +7.5%	5.11	USD 15,330
2020-11-04	2020-11-02	B Purchase	Novo Holdings A/S Large shareholder	333,333 +15.4% 15.00 USD 4,999,995	333,333 +15.4%	15.00	USD 4,999,995
2020-11-04	2020-11-02	B Purchase	Khuong Chau Quang Non-Executive Director Large shareholder	209,500 +25.5% 15.00 USD 3,142,500	209,500 +25.5%	15.00	USD 3,142,500
2020-11-04	2020-11-02	B Purchase	Khuong Chau Quang Non-Executive Director Large shareholder	523,833 +25.5% 15.00 USD 7,857,495	523,833 +25.5%	15.00	USD 7,857,495
2020-11-04	2020-11-02	B Purchase	Christgau Stephan Non-Executive Director	66,666 +13.9% 15.00 USD 999,990	66,666 +13.9%	15.00	USD 999,990
2020-11-04	2020-11-02	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	209,500 +25.5% 15.00 USD 3,142,500	209,500 +25.5%	15.00	USD 3,142,500
2020-11-04	2020-11-02	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	523,833 +25.5% 15.00 USD 7,857,495	523,833 +25.5%	15.00	USD 7,857,495

Galecto Inc (GLTO)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by